Filing Details

Accession Number:
0001127602-20-031131
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-10 20:24:21
Reporting Period:
2020-11-21
Accepted Time:
2020-12-10 20:24:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
203527 Varian Medical Systems Inc VAR Electromedical & Electrotherapeutic Apparatus (3845) 942359345
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1313996 R Dow Wilson C/O Varian Medical Systems, Inc.
3100 Hansen Way, M/S E-327
Palo Alto CA 94304
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-08 159,198 $109.03 280,643 No 4 M Direct
Common Stock Disposition 2020-12-08 159,198 $174.40 121,445 No 4 S Direct
Common Stock Disposition 2020-12-10 16,800 $0.00 104,645 No 5 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 5 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non Qualified Stock Option (Right to Buy) Acquisiton 2020-11-21 159,198 $109.03 159,198 $109.03
Common Stock Non Qualified Stock Option (Right to Buy) Disposition 2020-12-08 159,198 $0.00 159,198 $109.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
159,198 2020-11-21 2024-11-17 No 4 A Direct
0 2020-11-21 2024-11-17 No 4 M Direct
Footnotes
  1. This transaction is pursuant to the filer's SEC Rule 10b5-1 trading plan
  2. The 159,198 shares were sold in multiple transactions executed on the same day at prices ranging from $174.365 to $174.49. The detailed breakdown of executed sales will be furnished upon request.
  3. Represents performance-based stock option award granted on November 17, 2017 which vested on November 21, 2020, the date the Compensation Committee of the Board of Directors determined that the performance criteria were satisfied.